Industry Research Reports
Global Polynucleotides Injectable Market Research Report 2025
Industry: Consumer Goods
Published Date: 2025-03-10
Pages: 97 Pages
Report ld: 4623395
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Polynucleotides Injectable was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Polynucleotides injectables refer to medical and cosmetic treatments involving the injection of polynucleotide compounds, which are polymers composed of nucleotide monomers. These injectables are used in various applications due to their regenerative, anti-inflammatory, and tissue-repairing properties.
North American market for Polynucleotides Injectable is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Polynucleotides Injectable is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Polynucleotides Injectable include PharmaResearch Products Co., Ltd., Mastelli Srl, Promoitalia Group S.p.A., GUNA S.p.A., Caregen Co., Ltd., Medytox Inc., Suneva Medical, Inc., Euroresearch S.r.l., Anteis SA (now part of Merz Pharmaceuticals), Hyundai Pharm Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Polynucleotides Injectable, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polynucleotides Injectable.
The Polynucleotides Injectable market size, estimations, and forecasts are provided in terms of sales volume (Kilotons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Polynucleotides Injectable market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polynucleotides Injectable manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
PharmaResearch Products Co., Ltd.
Mastelli Srl
Promoitalia Group S.p.A.
GUNA S.p.A.
Caregen Co., Ltd.
Medytox Inc.
Suneva Medical, Inc.
Euroresearch S.r.l.
Anteis SA (now part of Merz Pharmaceuticals)
Hyundai Pharm Co., Ltd.
Regen Biotech, Inc.
Evolus, Inc.
Cleviel
Promedica International
NeoGenesis Co., Ltd.
Segment by Type
Eyes
Lips
Forehead
Jawline & Cheekbones
Others
Segment by Application
MedSpas
Aesthetic & Cosmetic Centers
Hospitals
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Polynucleotides Injectable manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Polynucleotides Injectable in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Polynucleotides Injectable Market Overview
1.1 Product Definition
1.2 Polynucleotides Injectable by Type
1.2.1 Global Polynucleotides Injectable Market Value Comparison by Type (2024 VS 2031)
1.2.2 Eyes
1.2.3 Lips
1.2.4 Forehead
1.2.5 Jawline & Cheekbones
1.2.6 Others
1.3 Polynucleotides Injectable by Application
1.3.1 Global Polynucleotides Injectable Market Value by Application (2024 VS 2031)
1.3.2 MedSpas
1.3.3 Aesthetic & Cosmetic Centers
1.3.4 Hospitals
1.4 Global Polynucleotides Injectable Market Size Estimates and Forecasts
1.4.1 Global Polynucleotides Injectable Revenue 2020-2031
1.4.2 Global Polynucleotides Injectable Sales 2020-2031
1.4.3 Global Polynucleotides Injectable Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Polynucleotides Injectable Market Competition by Manufacturers
2.1 Global Polynucleotides Injectable Sales Market Share by Manufacturers (2020-2025)
2.2 Global Polynucleotides Injectable Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Polynucleotides Injectable Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Polynucleotides Injectable, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Polynucleotides Injectable, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Polynucleotides Injectable, Product Type & Application
2.7 Global Key Manufacturers of Polynucleotides Injectable, Date of Enter into This Industry
2.8 Global Polynucleotides Injectable Market Competitive Situation and Trends
2.8.1 Global Polynucleotides Injectable Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Polynucleotides Injectable Players Market Share by Revenue
2.8.3 Global Polynucleotides Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Polynucleotides Injectable Market Scenario by Region
3.1 Global Polynucleotides Injectable Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Polynucleotides Injectable Sales by Region: 2020-2031
3.2.1 Global Polynucleotides Injectable Sales by Region: 2020-2025
3.2.2 Global Polynucleotides Injectable Sales by Region: 2026-2031
3.3 Global Polynucleotides Injectable Revenue by Region: 2020-2031
3.3.1 Global Polynucleotides Injectable Revenue by Region: 2020-2025
3.3.2 Global Polynucleotides Injectable Revenue by Region: 2026-2031
3.4 North America Polynucleotides Injectable Market Facts & Figures by Country
3.4.1 North America Polynucleotides Injectable Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Polynucleotides Injectable Sales by Country (2020-2031)
3.4.3 North America Polynucleotides Injectable Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Polynucleotides Injectable Market Facts & Figures by Country
3.5.1 Europe Polynucleotides Injectable Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Polynucleotides Injectable Sales by Country (2020-2031)
3.5.3 Europe Polynucleotides Injectable Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Polynucleotides Injectable Market Facts & Figures by Region
3.6.1 Asia Pacific Polynucleotides Injectable Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Polynucleotides Injectable Sales by Region (2020-2031)
3.6.3 Asia Pacific Polynucleotides Injectable Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Polynucleotides Injectable Market Facts & Figures by Country
3.7.1 Latin America Polynucleotides Injectable Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Polynucleotides Injectable Sales by Country (2020-2031)
3.7.3 Latin America Polynucleotides Injectable Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Polynucleotides Injectable Market Facts & Figures by Country
3.8.1 Middle East and Africa Polynucleotides Injectable Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Polynucleotides Injectable Sales by Country (2020-2031)
3.8.3 Middle East and Africa Polynucleotides Injectable Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Polynucleotides Injectable Sales by Type (2020-2031)
4.1.1 Global Polynucleotides Injectable Sales by Type (2020-2025)
4.1.2 Global Polynucleotides Injectable Sales by Type (2026-2031)
4.1.3 Global Polynucleotides Injectable Sales Market Share by Type (2020-2031)
4.2 Global Polynucleotides Injectable Revenue by Type (2020-2031)
4.2.1 Global Polynucleotides Injectable Revenue by Type (2020-2025)
4.2.2 Global Polynucleotides Injectable Revenue by Type (2026-2031)
4.2.3 Global Polynucleotides Injectable Revenue Market Share by Type (2020-2031)
4.3 Global Polynucleotides Injectable Price by Type (2020-2031)
5 Segment by Application
5.1 Global Polynucleotides Injectable Sales by Application (2020-2031)
5.1.1 Global Polynucleotides Injectable Sales by Application (2020-2025)
5.1.2 Global Polynucleotides Injectable Sales by Application (2026-2031)
5.1.3 Global Polynucleotides Injectable Sales Market Share by Application (2020-2031)
5.2 Global Polynucleotides Injectable Revenue by Application (2020-2031)
5.2.1 Global Polynucleotides Injectable Revenue by Application (2020-2025)
5.2.2 Global Polynucleotides Injectable Revenue by Application (2026-2031)
5.2.3 Global Polynucleotides Injectable Revenue Market Share by Application (2020-2031)
5.3 Global Polynucleotides Injectable Price by Application (2020-2031)
6 Key Companies Profiled
6.1 PharmaResearch Products Co., Ltd.
6.1.1 PharmaResearch Products Co., Ltd. Company Information
6.1.2 PharmaResearch Products Co., Ltd. Description and Business Overview
6.1.3 PharmaResearch Products Co., Ltd. Polynucleotides Injectable Sales, Revenue and Gross Margin (2020-2025)
6.1.4 PharmaResearch Products Co., Ltd. Polynucleotides Injectable Product Portfolio
6.1.5 PharmaResearch Products Co., Ltd. Recent Developments/Updates
6.2 Mastelli Srl
6.2.1 Mastelli Srl Company Information
6.2.2 Mastelli Srl Description and Business Overview
6.2.3 Mastelli Srl Polynucleotides Injectable Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mastelli Srl Polynucleotides Injectable Product Portfolio
6.2.5 Mastelli Srl Recent Developments/Updates
6.3 Promoitalia Group S.p.A.
6.3.1 Promoitalia Group S.p.A. Company Information
6.3.2 Promoitalia Group S.p.A. Description and Business Overview
6.3.3 Promoitalia Group S.p.A. Polynucleotides Injectable Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Promoitalia Group S.p.A. Polynucleotides Injectable Product Portfolio
6.3.5 Promoitalia Group S.p.A. Recent Developments/Updates
6.4 GUNA S.p.A.
6.4.1 GUNA S.p.A. Company Information
6.4.2 GUNA S.p.A. Description and Business Overview
6.4.3 GUNA S.p.A. Polynucleotides Injectable Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GUNA S.p.A. Polynucleotides Injectable Product Portfolio
6.4.5 GUNA S.p.A. Recent Developments/Updates
6.5 Caregen Co., Ltd.
6.5.1 Caregen Co., Ltd. Company Information
6.5.2 Caregen Co., Ltd. Description and Business Overview
6.5.3 Caregen Co., Ltd. Polynucleotides Injectable Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Caregen Co., Ltd. Polynucleotides Injectable Product Portfolio
6.5.5 Caregen Co., Ltd. Recent Developments/Updates
6.6 Medytox Inc.
6.6.1 Medytox Inc. Company Information
6.6.2 Medytox Inc. Description and Business Overview
6.6.3 Medytox Inc. Polynucleotides Injectable Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Medytox Inc. Polynucleotides Injectable Product Portfolio
6.6.5 Medytox Inc. Recent Developments/Updates
6.7 Suneva Medical, Inc.
6.7.1 Suneva Medical, Inc. Company Information
6.7.2 Suneva Medical, Inc. Description and Business Overview
6.7.3 Suneva Medical, Inc. Polynucleotides Injectable Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Suneva Medical, Inc. Polynucleotides Injectable Product Portfolio
6.7.5 Suneva Medical, Inc. Recent Developments/Updates
6.8 Euroresearch S.r.l.
6.8.1 Euroresearch S.r.l. Company Information
6.8.2 Euroresearch S.r.l. Description and Business Overview
6.8.3 Euroresearch S.r.l. Polynucleotides Injectable Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Euroresearch S.r.l. Polynucleotides Injectable Product Portfolio
6.8.5 Euroresearch S.r.l. Recent Developments/Updates
6.9 Anteis SA (now part of Merz Pharmaceuticals)
6.9.1 Anteis SA (now part of Merz Pharmaceuticals) Company Information
6.9.2 Anteis SA (now part of Merz Pharmaceuticals) Description and Business Overview
6.9.3 Anteis SA (now part of Merz Pharmaceuticals) Polynucleotides Injectable Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Anteis SA (now part of Merz Pharmaceuticals) Polynucleotides Injectable Product Portfolio
6.9.5 Anteis SA (now part of Merz Pharmaceuticals) Recent Developments/Updates
6.10 Hyundai Pharm Co., Ltd.
6.10.1 Hyundai Pharm Co., Ltd. Company Information
6.10.2 Hyundai Pharm Co., Ltd. Description and Business Overview
6.10.3 Hyundai Pharm Co., Ltd. Polynucleotides Injectable Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Hyundai Pharm Co., Ltd. Polynucleotides Injectable Product Portfolio
6.10.5 Hyundai Pharm Co., Ltd. Recent Developments/Updates
6.11 Regen Biotech, Inc.
6.11.1 Regen Biotech, Inc. Company Information
6.11.2 Regen Biotech, Inc. Description and Business Overview
6.11.3 Regen Biotech, Inc. Polynucleotides Injectable Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Regen Biotech, Inc. Polynucleotides Injectable Product Portfolio
6.11.5 Regen Biotech, Inc. Recent Developments/Updates
6.12 Evolus, Inc.
6.12.1 Evolus, Inc. Company Information
6.12.2 Evolus, Inc. Description and Business Overview
6.12.3 Evolus, Inc. Polynucleotides Injectable Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Evolus, Inc. Polynucleotides Injectable Product Portfolio
6.12.5 Evolus, Inc. Recent Developments/Updates
6.13 Cleviel
6.13.1 Cleviel Company Information
6.13.2 Cleviel Description and Business Overview
6.13.3 Cleviel Polynucleotides Injectable Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Cleviel Polynucleotides Injectable Product Portfolio
6.13.5 Cleviel Recent Developments/Updates
6.14 Promedica International
6.14.1 Promedica International Company Information
6.14.2 Promedica International Description and Business Overview
6.14.3 Promedica International Polynucleotides Injectable Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Promedica International Polynucleotides Injectable Product Portfolio
6.14.5 Promedica International Recent Developments/Updates
6.15 NeoGenesis Co., Ltd.
6.15.1 NeoGenesis Co., Ltd. Company Information
6.15.2 NeoGenesis Co., Ltd. Description and Business Overview
6.15.3 NeoGenesis Co., Ltd. Polynucleotides Injectable Sales, Revenue and Gross Margin (2020-2025)
6.15.4 NeoGenesis Co., Ltd. Polynucleotides Injectable Product Portfolio
6.15.5 NeoGenesis Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Polynucleotides Injectable Industry Chain Analysis
7.2 Polynucleotides Injectable Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Polynucleotides Injectable Production Mode & Process Analysis
7.4 Polynucleotides Injectable Sales and Marketing
7.4.1 Polynucleotides Injectable Sales Channels
7.4.2 Polynucleotides Injectable Distributors
7.5 Polynucleotides Injectable Customer Analysis
8 Polynucleotides Injectable Market Dynamics
8.1 Polynucleotides Injectable Industry Trends
8.2 Polynucleotides Injectable Market Drivers
8.3 Polynucleotides Injectable Market Challenges
8.4 Polynucleotides Injectable Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Polynucleotides Injectable Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Polynucleotides Injectable Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Polynucleotides Injectable Market Competitive Situation by Manufacturers in 2024
Table 4. Global Polynucleotides Injectable Sales (Kilotons) of Key Manufacturers (2020-2025)
Table 5. Global Polynucleotides Injectable Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Polynucleotides Injectable Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Polynucleotides Injectable Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Polynucleotides Injectable Average Price (US$/Ton) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Polynucleotides Injectable, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Polynucleotides Injectable, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Polynucleotides Injectable, Product Type & Application
Table 12. Global Key Manufacturers of Polynucleotides Injectable, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Polynucleotides Injectable by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polynucleotides Injectable as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Polynucleotides Injectable Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Polynucleotides Injectable Sales by Region (2020-2025) & (Kilotons)
Table 18. Global Polynucleotides Injectable Sales Market Share by Region (2020-2025)
Table 19. Global Polynucleotides Injectable Sales by Region (2026-2031) & (Kilotons)
Table 20. Global Polynucleotides Injectable Sales Market Share by Region (2026-2031)
Table 21. Global Polynucleotides Injectable Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Polynucleotides Injectable Revenue Market Share by Region (2020-2025)
Table 23. Global Polynucleotides Injectable Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Polynucleotides Injectable Revenue Market Share by Region (2026-2031)
Table 25. North America Polynucleotides Injectable Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Polynucleotides Injectable Sales by Country (2020-2025) & (Kilotons)
Table 27. North America Polynucleotides Injectable Sales by Country (2026-2031) & (Kilotons)
Table 28. North America Polynucleotides Injectable Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Polynucleotides Injectable Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Polynucleotides Injectable Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Polynucleotides Injectable Sales by Country (2020-2025) & (Kilotons)
Table 32. Europe Polynucleotides Injectable Sales by Country (2026-2031) & (Kilotons)
Table 33. Europe Polynucleotides Injectable Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Polynucleotides Injectable Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Polynucleotides Injectable Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Polynucleotides Injectable Sales by Region (2020-2025) & (Kilotons)
Table 37. Asia Pacific Polynucleotides Injectable Sales by Region (2026-2031) & (Kilotons)
Table 38. Asia Pacific Polynucleotides Injectable Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Polynucleotides Injectable Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Polynucleotides Injectable Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Polynucleotides Injectable Sales by Country (2020-2025) & (Kilotons)
Table 42. Latin America Polynucleotides Injectable Sales by Country (2026-2031) & (Kilotons)
Table 43. Latin America Polynucleotides Injectable Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Polynucleotides Injectable Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Polynucleotides Injectable Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Polynucleotides Injectable Sales by Country (2020-2025) & (Kilotons)
Table 47. Middle East and Africa Polynucleotides Injectable Sales by Country (2026-2031) & (Kilotons)
Table 48. Middle East and Africa Polynucleotides Injectable Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Polynucleotides Injectable Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Polynucleotides Injectable Sales (Kilotons) by Type (2020-2025)
Table 51. Global Polynucleotides Injectable Sales (Kilotons) by Type (2026-2031)
Table 52. Global Polynucleotides Injectable Sales Market Share by Type (2020-2025)
Table 53. Global Polynucleotides Injectable Sales Market Share by Type (2026-2031)
Table 54. Global Polynucleotides Injectable Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Polynucleotides Injectable Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Polynucleotides Injectable Revenue Market Share by Type (2020-2025)
Table 57. Global Polynucleotides Injectable Revenue Market Share by Type (2026-2031)
Table 58. Global Polynucleotides Injectable Price (US$/Ton) by Type (2020-2025)
Table 59. Global Polynucleotides Injectable Price (US$/Ton) by Type (2026-2031)
Table 60. Global Polynucleotides Injectable Sales (Kilotons) by Application (2020-2025)
Table 61. Global Polynucleotides Injectable Sales (Kilotons) by Application (2026-2031)
Table 62. Global Polynucleotides Injectable Sales Market Share by Application (2020-2025)
Table 63. Global Polynucleotides Injectable Sales Market Share by Application (2026-2031)
Table 64. Global Polynucleotides Injectable Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Polynucleotides Injectable Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Polynucleotides Injectable Revenue Market Share by Application (2020-2025)
Table 67. Global Polynucleotides Injectable Revenue Market Share by Application (2026-2031)
Table 68. Global Polynucleotides Injectable Price (US$/Ton) by Application (2020-2025)
Table 69. Global Polynucleotides Injectable Price (US$/Ton) by Application (2026-2031)
Table 70. PharmaResearch Products Co., Ltd. Company Information
Table 71. PharmaResearch Products Co., Ltd. Description and Business Overview
Table 72. PharmaResearch Products Co., Ltd. Polynucleotides Injectable Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 73. PharmaResearch Products Co., Ltd. Polynucleotides Injectable Product
Table 74. PharmaResearch Products Co., Ltd. Recent Developments/Updates
Table 75. Mastelli Srl Company Information
Table 76. Mastelli Srl Description and Business Overview
Table 77. Mastelli Srl Polynucleotides Injectable Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 78. Mastelli Srl Polynucleotides Injectable Product
Table 79. Mastelli Srl Recent Developments/Updates
Table 80. Promoitalia Group S.p.A. Company Information
Table 81. Promoitalia Group S.p.A. Description and Business Overview
Table 82. Promoitalia Group S.p.A. Polynucleotides Injectable Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 83. Promoitalia Group S.p.A. Polynucleotides Injectable Product
Table 84. Promoitalia Group S.p.A. Recent Developments/Updates
Table 85. GUNA S.p.A. Company Information
Table 86. GUNA S.p.A. Description and Business Overview
Table 87. GUNA S.p.A. Polynucleotides Injectable Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 88. GUNA S.p.A. Polynucleotides Injectable Product
Table 89. GUNA S.p.A. Recent Developments/Updates
Table 90. Caregen Co., Ltd. Company Information
Table 91. Caregen Co., Ltd. Description and Business Overview
Table 92. Caregen Co., Ltd. Polynucleotides Injectable Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Caregen Co., Ltd. Polynucleotides Injectable Product
Table 94. Caregen Co., Ltd. Recent Developments/Updates
Table 95. Medytox Inc. Company Information
Table 96. Medytox Inc. Description and Business Overview
Table 97. Medytox Inc. Polynucleotides Injectable Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 98. Medytox Inc. Polynucleotides Injectable Product
Table 99. Medytox Inc. Recent Developments/Updates
Table 100. Suneva Medical, Inc. Company Information
Table 101. Suneva Medical, Inc. Description and Business Overview
Table 102. Suneva Medical, Inc. Polynucleotides Injectable Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 103. Suneva Medical, Inc. Polynucleotides Injectable Product
Table 104. Suneva Medical, Inc. Recent Developments/Updates
Table 105. Euroresearch S.r.l. Company Information
Table 106. Euroresearch S.r.l. Description and Business Overview
Table 107. Euroresearch S.r.l. Polynucleotides Injectable Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 108. Euroresearch S.r.l. Polynucleotides Injectable Product
Table 109. Euroresearch S.r.l. Recent Developments/Updates
Table 110. Anteis SA (now part of Merz Pharmaceuticals) Company Information
Table 111. Anteis SA (now part of Merz Pharmaceuticals) Description and Business Overview
Table 112. Anteis SA (now part of Merz Pharmaceuticals) Polynucleotides Injectable Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 113. Anteis SA (now part of Merz Pharmaceuticals) Polynucleotides Injectable Product
Table 114. Anteis SA (now part of Merz Pharmaceuticals) Recent Developments/Updates
Table 115. Hyundai Pharm Co., Ltd. Company Information
Table 116. Hyundai Pharm Co., Ltd. Description and Business Overview
Table 117. Hyundai Pharm Co., Ltd. Polynucleotides Injectable Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 118. Hyundai Pharm Co., Ltd. Polynucleotides Injectable Product
Table 119. Hyundai Pharm Co., Ltd. Recent Developments/Updates
Table 120. Regen Biotech, Inc. Company Information
Table 121. Regen Biotech, Inc. Description and Business Overview
Table 122. Regen Biotech, Inc. Polynucleotides Injectable Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 123. Regen Biotech, Inc. Polynucleotides Injectable Product
Table 124. Regen Biotech, Inc. Recent Developments/Updates
Table 125. Evolus, Inc. Company Information
Table 126. Evolus, Inc. Description and Business Overview
Table 127. Evolus, Inc. Polynucleotides Injectable Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 128. Evolus, Inc. Polynucleotides Injectable Product
Table 129. Evolus, Inc. Recent Developments/Updates
Table 130. Cleviel Company Information
Table 131. Cleviel Description and Business Overview
Table 132. Cleviel Polynucleotides Injectable Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 133. Cleviel Polynucleotides Injectable Product
Table 134. Cleviel Recent Developments/Updates
Table 135. Promedica International Company Information
Table 136. Promedica International Description and Business Overview
Table 137. Promedica International Polynucleotides Injectable Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 138. Promedica International Polynucleotides Injectable Product
Table 139. Promedica International Recent Developments/Updates
Table 140. NeoGenesis Co., Ltd. Company Information
Table 141. NeoGenesis Co., Ltd. Description and Business Overview
Table 142. NeoGenesis Co., Ltd. Polynucleotides Injectable Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 143. NeoGenesis Co., Ltd. Polynucleotides Injectable Product
Table 144. NeoGenesis Co., Ltd. Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Polynucleotides Injectable Distributors List
Table 148. Polynucleotides Injectable Customers List
Table 149. Polynucleotides Injectable Market Trends
Table 150. Polynucleotides Injectable Market Drivers
Table 151. Polynucleotides Injectable Market Challenges
Table 152. Polynucleotides Injectable Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Polynucleotides Injectable
Figure 2. Global Polynucleotides Injectable Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Polynucleotides Injectable Market Share by Type: 2024 & 2031
Figure 4. Eyes Product Picture
Figure 5. Lips Product Picture
Figure 6. Forehead Product Picture
Figure 7. Jawline & Cheekbones Product Picture
Figure 8. Others Product Picture
Figure 9. Global Polynucleotides Injectable Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Polynucleotides Injectable Market Share by Application: 2024 & 2031
Figure 11. MedSpas
Figure 12. Aesthetic & Cosmetic Centers
Figure 13. Hospitals
Figure 14. Global Polynucleotides Injectable Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Polynucleotides Injectable Market Size (2020-2031) & (US$ Million)
Figure 16. Global Polynucleotides Injectable Sales (2020-2031) & (Kilotons)
Figure 17. Global Polynucleotides Injectable Average Price (US$/Ton) & (2020-2031)
Figure 18. Polynucleotides Injectable Report Years Considered
Figure 19. Polynucleotides Injectable Sales Share by Manufacturers in 2024
Figure 20. Global Polynucleotides Injectable Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Polynucleotides Injectable Players: Market Share by Revenue in Polynucleotides Injectable in 2024
Figure 22. Polynucleotides Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Polynucleotides Injectable Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Polynucleotides Injectable Sales Market Share by Country (2020-2031)
Figure 25. North America Polynucleotides Injectable Revenue Market Share by Country (2020-2031)
Figure 26. United States Polynucleotides Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Polynucleotides Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Polynucleotides Injectable Sales Market Share by Country (2020-2031)
Figure 29. Europe Polynucleotides Injectable Revenue Market Share by Country (2020-2031)
Figure 30. Germany Polynucleotides Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Polynucleotides Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Polynucleotides Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Polynucleotides Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Polynucleotides Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Polynucleotides Injectable Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Polynucleotides Injectable Revenue Market Share by Region (2020-2031)
Figure 37. China Polynucleotides Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Polynucleotides Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Polynucleotides Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Polynucleotides Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Polynucleotides Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Polynucleotides Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Polynucleotides Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Polynucleotides Injectable Sales Market Share by Country (2020-2031)
Figure 45. Latin America Polynucleotides Injectable Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Polynucleotides Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Polynucleotides Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Polynucleotides Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Colombia Polynucleotides Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Polynucleotides Injectable Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Polynucleotides Injectable Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Polynucleotides Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Polynucleotides Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Polynucleotides Injectable Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Polynucleotides Injectable by Type (2020-2031)
Figure 56. Global Revenue Market Share of Polynucleotides Injectable by Type (2020-2031)
Figure 57. Global Polynucleotides Injectable Price (US$/Ton) by Type (2020-2031)
Figure 58. Global Sales Market Share of Polynucleotides Injectable by Application (2020-2031)
Figure 59. Global Revenue Market Share of Polynucleotides Injectable by Application (2020-2031)
Figure 60. Global Polynucleotides Injectable Price (US$/Ton) by Application (2020-2031)
Figure 61. Polynucleotides Injectable Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Polynucleotides Injectable market?
The top companies in the global Polynucleotides Injectable market are PharmaResearch Products Co., Ltd.、Mastelli Srl、Promoitalia Group S.p.A..
Related Reports
Global Polynucleotides Injectable Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Polynucleotides Injectable market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 153
USD 4900.00
(Single User License)
Global Polynucleotides Injectable Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Polynucleotides Injectable market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 98
USD 4250.00
(Single User License)
Polynucleotides Injectable- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Polynucleotides Injectable was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 124
USD 3950.00
(Single User License)
Global Polynucleotides Injectable Market Research Report 2026
The global Polynucleotides Injectable market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 126
USD 2900.00
(Single User License)
Global Polynucleotides Injectable Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Polynucleotides Injectable market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 166
USD 4900.00
(Single User License)
Global Polynucleotides Injectable Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Polynucleotides Injectable market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 93
USD 4250.00
(Single User License)
Polynucleotides Injectable - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Polynucleotides Injectable was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 117
USD 3950.00
(Single User License)
Global Polynucleotides Injectable Market Research Report 2024
Polynucleotides injectables refer to medical and cosmetic treatments involving the injection of polynucleotide compounds, which are polymers composed of nucleotide monomers. These injectables are used in various applications due to their regenerative, anti-inflammatory, and tissue-repairing properties.
Published Date: 2024-07-26
Pages: 95
USD 2900.00
(Single User License)
Global Polynucleotides Injectable Market Insights, Forecast to 2030
Polynucleotides injectables refer to medical and cosmetic treatments involving the injection of polynucleotide compounds, which are polymers composed of nucleotide monomers. These injectables are used in various applications due to their regenerative, anti-inflammatory, and tissue-repairing properties.
Published Date: 2024-07-26
Pages: 154
USD 4900.00
(Single User License)
Global and United States Polynucleotides Injectable Market Report & Forecast 2024-2030
Polynucleotides injectables refer to medical and cosmetic treatments involving the injection of polynucleotide compounds, which are polymers composed of nucleotide monomers. These injectables are used in various applications due to their regenerative, anti-inflammatory, and tissue-repairing properties.
Published Date: 2024-07-26
Pages: 123
USD 4350.00
(Single User License)
Global Polynucleotides Injectable Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Polynucleotides Injectable market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 153
USD 4900.00 (Single User License)Global Polynucleotides Injectable Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Polynucleotides Injectable market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 98
USD 4250.00 (Single User License)Polynucleotides Injectable- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Polynucleotides Injectable was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 124
USD 3950.00 (Single User License)Global Polynucleotides Injectable Market Research Report 2026
The global Polynucleotides Injectable market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 126
USD 2900.00 (Single User License)Global Polynucleotides Injectable Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Polynucleotides Injectable market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 166
USD 4900.00 (Single User License)Global Polynucleotides Injectable Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Polynucleotides Injectable market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 93
USD 4250.00 (Single User License)Polynucleotides Injectable - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Polynucleotides Injectable was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 117
USD 3950.00 (Single User License)Global Polynucleotides Injectable Market Research Report 2024
Polynucleotides injectables refer to medical and cosmetic treatments involving the injection of polynucleotide compounds, which are polymers composed of nucleotide monomers. These injectables are used in various applications due to their regenerative, anti-inflammatory, and tissue-repairing properties.
Published: 2024-07-26
Pages: 95
USD 2900.00 (Single User License)Global Polynucleotides Injectable Market Insights, Forecast to 2030
Polynucleotides injectables refer to medical and cosmetic treatments involving the injection of polynucleotide compounds, which are polymers composed of nucleotide monomers. These injectables are used in various applications due to their regenerative, anti-inflammatory, and tissue-repairing properties.
Published: 2024-07-26
Pages: 154
USD 4900.00 (Single User License)Global and United States Polynucleotides Injectable Market Report & Forecast 2024-2030
Polynucleotides injectables refer to medical and cosmetic treatments involving the injection of polynucleotide compounds, which are polymers composed of nucleotide monomers. These injectables are used in various applications due to their regenerative, anti-inflammatory, and tissue-repairing properties.
Published: 2024-07-26
Pages: 123
USD 4350.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now